Tonix Pharmaceuticals Holding May Sell Up To $150 Million In Common Stock

ReutersJun 11, 2025 9:26 PM

June 11 (Reuters) - Tonix Pharmaceuticals Holding Corp TNXP.O:

TONIX PHARMACEUTICALS HOLDING CORP - MAY SELL UP TO $150 MILLION IN COMMON STOCK - SEC FILING
TONIX PHARMACEUTICALS HOLDING CORP - ENTERS $75 MILLION PURCHASE AGREEMENT WITH LINCOLN PARK - SEC FILING

Source text: [ID:n0001999371-25-007625]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Intel Better-Than-Expected Earnings Released, Stock Surges 20% After-Hours, AI Computing Power Enters CPU Moment?

TradingKey - Driven by the global boom in AI infrastructure construction, demand for server chips is seeing explosive growth. Intel (INTC), which fell behind in the early stages of the AI race, is accelerating its recovery on the back of better-than-expected earnings.

Today’s Market Recap: Iran Tensions Stir Market, U.S. Stocks Dip as Intel Soars 20% in After-Hours Trading

TradingKey - On April 23, 2026, Thursday, the S&P 500 declined by 0.42% to 7,108, while the Nasdaq Composite fell 0.89% to close at 24,439.

Intel Foundry Gains ‘High-Profile’ Customer, Tesla Becomes First Major Customer for 14A Technology

TradingKey - On April 23, Intel (INTC.US) shares rose as much as 2% in pre-market trading before paring gains. This follows an announcement by Tesla CEO Elon Musk that Tesla will use Intel's advanced 14A manufacturing process to produce AI chips for its Terafab project, making Tesla the first major customer for Intel's 14A technology.

Anthropic Eclipses OpenAI in Secondary Market as Valuation Hits $1 Trillion Milestone, Is the AI Market Overheating Now?

TradingKey - According to a report by Business Insider, AI startup Anthropic's valuation in the private secondary market has surpassed $1 trillion, overtaking OpenAI.

Intel Stock Has Surged 74% in 2026 and Earnings Land April 23 — Is INTC Still a Buy at $68?

TradingKey - Intel surged 74% YTD and hit 26-year highs near $70. Q1 2026 earnings drop April 23. RSI overbought at 78. Key support $63, resistance $72.50. Buy or fade?

Featured Tools